Prof. Songbing He | The First Affiliated Hospital of Soochow University | China
Dr. Songbing He is a distinguished colorectal cancer researcher π₯ and surgeon π¬ at The First Affiliated Hospital of Soochow University, China π¨π³. With a strong background in immunomodulation π¦ and immunometabolism π₯, he has contributed significantly to both basic and clinical research π. His work explores innovative treatments π‘ for colorectal cancer, integrating immunotherapy π and metabolism-based interventions β‘. Dr. He has held key positions in prestigious institutions, including Washington University in St. Louis πΊπΈ. His research has led to impactful publications π, accumulating over 200 citations π’. As a dedicated academic π and clinician π₯, Dr. He continues to advance the field of gastrointestinal oncology π.
Professional Profile:
Google Scholar
SCOPUS
Suitability for Best Researcher Award
Dr. Songbing He is a renowned researcher and surgeon specializing in colorectal cancer at The First Affiliated Hospital of Soochow University, China π₯. His expertise in immunomodulation 𧬠and immunometabolism π₯ has greatly advanced colorectal cancer research. His innovative approach πβintegrating immunotherapy π with metabolism-based interventionsβhighlights his pioneering role in developing novel cancer treatment strategies.
Education & Experience ππΌ
- Ph.D. in Surgery (2009-2012) π₯ β Soochow University, China
- Masterβs Degree in Surgery (2003-2006) π©Ί β Soochow University, China
- Bachelorβs Degree in Clinical Medicine (1998-2003) π β Jiangsu University, China
- Research Fellow (2013-Present) π¬ β Washington University in St. Louis, USA
- Postdoctoral Researcher (2012-2013) π§ͺ β Shanghai Jiao Tong University, China
- Attending Doctor & Lecturer (2009-2013) π¨ββοΈ β The First Affiliated Hospital of Soochow University
- Resident & Teaching Assistant (2006-2009) π₯ β The First Affiliated Hospital of Soochow University
Professional Development ππ
Dr. Heβs career is marked by continuous learning and global collaborations. At Washington University, he explored the intersection of nutrition, immunology, and colorectal cancer, fostering advancements in immunometabolism. His postdoctoral tenure at Shanghai Jiao Tong University further refined his expertise in tumor immunology. As a lecturer and attending physician, he has mentored young researchers and medical students, contributing to medical education. His participation in international conferences and editorial roles in scientific journals reflects his dedication to knowledge dissemination. Through innovative research and interdisciplinary collaborations, Dr. He remains at the forefront of colorectal cancer advancements.
Research Focus π¬π¦
Dr. Songbing Heβs research primarily revolves around colorectal cancer with a focus on tumor immunology and metabolism. He investigates how the immune system interacts with tumor cells and explores ways to manipulate these interactions for improved therapies. His expertise extends to immunometabolism, where he examines how metabolic changes within immune cells affect cancer progression. Additionally, he explores novel biomarkers for early detection and personalized treatment strategies. His work integrates basic science with clinical applications, bridging the gap between laboratory discoveries and patient care, ultimately aiming for more effective and less toxic cancer treatments.
Awards & Honors ππ
- Outstanding Researcher Award π
β Soochow University
- Best Paper Award π β International Colorectal Cancer Conference
- Excellent Young Scholar Grant π° β National Natural Science Foundation of China
- Top Reviewer Recognition π
β Leading Oncology Journals
- Travel Grant for Young Scientists βοΈ β International Immunology Congress
Publication Top Notes :
Β π Effects of moderate and subsequent progressive weight loss on metabolic function and adipose tissue biology in humans with obesity | π₯ 928 citations | ποΈ Cell Metabolism
Β π Distribution and clinical significance of Th17 cells in the tumor microenvironment and peripheral blood of pancreatic cancer patients | π₯ 174 citations | ποΈ International Journal of Molecular Sciences
π Salinomycin induces apoptosis in cisplatin-resistant colorectal cancer cells by accumulation of reactive oxygen species | π₯ 121 citations | ποΈ Toxicology Letters
π Clinicopathologic Significance of HIFβ1Ξ±, CXCR4, and VEGF Expression in Colon Cancer | π₯ 101 citations | ποΈ Journal of Immunology Research
π Downregulation of enhancer of zeste homolog 2 (EZH2) is essential for the induction of autophagy and apoptosis in colorectal cancer cells | π₯ 87 citations | ποΈ Genes
πΒ MicroRNA-375 targets PDK1 in pancreatic carcinoma and suppresses cell growth through the Akt signaling pathway | π₯ 83 citations | ποΈ International Journal of Molecular Medicine